Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Central Venous Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Central Venous Catheters under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Central Venous Catheters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Central Venous Catheters Overview
4 Products under Development
4.1 Central Venous Catheters - Pipeline Products by Stage of Development
4.2 Central Venous Catheters - Pipeline Products by Segment
4.3 Central Venous Catheters - Pipeline Products by Territory
4.4 Central Venous Catheters - Pipeline Products by Regulatory Path
4.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date
5 Central Venous Catheters - Pipeline Products under Development by Companies
5.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development
5.2 Central Venous Catheters – Companies Pipeline Products by Stage of Development
6 Central Venous Catheters Companies and Product Overview
8.1 May 16, 2023: PAVmed provides business update and Q1 financial results
8.2 May 05, 2023: PAVmed to hold a business update conference call and webcast on May 17, 2023
8.3 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
8.4 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
8.5 Mar 14, 2023: PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
8.6 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
8.7 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
8.8 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
8.9 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
8.10 Dec 15, 2022: PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
8.11 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
8.12 Dec 08, 2022: T2 Biosystems highlights peer-reviewed article linking COVID-19 and sepsis and underscoring CDC call for adoption of early and accurate microbial diagnosis to guide targeted initial antimicrobial therapy
8.13 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
8.14 Nov 15, 2022: PAVmed Provides Business Update and Third Quarter 2022 Financial Results
8.15 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022
8.16 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
8.17 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
8.18 Sep 15, 2022: Lifecome Biochemistry Co. Announces resignation of the company's directors
8.19 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference
8.20 Aug 16, 2022: Pavmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
8.21 Aug 15, 2022: Retractable Technologies Announces Results for the Periods Ended June 30, 2022
8.22 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022
9 Appendix
9.1 Methodology
9.2 About GlobalData
9.3 Contact Us
9.4 Disclaimer
2.1 List of Tables
Table 1: Central Venous Catheters - Pipeline Products by Stage of Development
Table 2: Central Venous Catheters - Pipeline Products by Segment
Table 3: Central Venous Catheters - Pipeline Products by Territory
Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path
Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date
Table 6: Central Venous Catheters Companies - Pipeline Products by Stage of Development
Table 7: Central Venous Catheters – Companies Pipeline Products by Stage of Development